s
SIFI Receives COMP Positive Opinion on Orphan Drug Designation for Polihexanide in Treating Fungal Keratitis
22-07-2024, 09:37
ACI SANT’ANTONIO, Italy, July 22, 2024 /PRNewswire/ — SIFI, a leading international ophthalmic company headquartered in Italy, is pleased to announce that the Committee for Orphan Medicinal Products (COMP) of the European Medicine Agency (EMA) has issued a positive opinion concerning Orphan Drug Designation (ODD) for polihexanide in the treatment of fungal keratitis. This designation follows […] L'articolo SIFI Receives COMP Positive Opinion on Orphan Drug Designation for Polihexanide in Treating Fungal Keratitis proviene da La Ragione.
CONTINUA A LEGGERE
7
0
0
Guarda anche
La Ragione
14:07
Le iterazioni più desiderate
La Ragione
13:58